Estrogen receptor imaging agents
US10385093B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2013 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Dec 10, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/0015
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds useful for molecular imaging of cells expressing estrogen receptors are provided. Also provided are intermediates for making the compounds and methods of making the compounds using a modular convergent strategy. Further, methods of making the intermediates are described, as well as methods of diagnosing disease in a subject by using the compounds as imaging agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.